Absorption |
Blood-Brain Barrier | BBB+ | 0.8369 |
Human Intestinal Absorption | HIA+ | 0.9968 |
Caco-2 Permeability | Caco2+ | 0.5576 |
P-glycoprotein Substrate | Substrate | 0.6532 |
P-glycoprotein Inhibitor | Inhibitor | 0.7971 |
Inhibitor | 0.5926 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7189 |
Distribution |
Subcellular localization | Mitochondria | 0.7705 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8277 |
CYP450 2D6 Substrate | Non-substrate | 0.8863 |
CYP450 3A4 Substrate | Substrate | 0.5527 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9055 |
CYP450 2C9 Inhibitor | Inhibitor | 0.8278 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7167 |
CYP450 2C19 Inhibitor | Inhibitor | 0.9153 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7687 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9416 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9070 |
Non-inhibitor | 0.9034 |
AMES Toxicity | AMES toxic | 0.9226 |
Carcinogens | Non-carcinogens | 0.9347 |
Fish Toxicity | High FHMT | 0.9954 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9928 |
Honey Bee Toxicity | High HBT | 0.9007 |
Biodegradation | Not ready biodegradable | 0.6754 |
Acute Oral Toxicity | III | 0.6372 |
Carcinogenicity (Three-class) | Non-required | 0.5953 |